CTRI stock has a bearish outlook. Analysts from J.P. Morgan and Bank of America maintain Sell ratings with price targets of $19 and $16.50, respectively, citing weak earnings performance and a downside potential of over 9% from its current price of $21. Additionally, Q2 2024 earnings missed both EPS and revenue expectations, reflecting operational challenges.